A Study to Establish the Feasibility of Biolen for the Local Delivery of Bicalutamide in Patients With Prostate Cancer

NCT04284761 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Adenocarcinoma
Lower Urinary Tract Symptoms

Interventions

COMBINATION_PRODUCT: Bicalutamide implant

Sponsor

Alessa Therapeutics Inc.